A living WHO guideline on drugs for covid-19
ContributorsLamontagne, François; Agoritsas, Thomas; Macdonald, Helen; Leo, Yee-Sin; Diaz, Janet; Agarwal, Arnav; Appiah, John Adabie; Arabi, Yaseen; Blumberg, Lucille; Calfee, Carolyn S; Cao, Bin; Cecconi, Maurizio; Cooke, Graham; Dunning, Jake; Geduld, Heike; Gee, Patrick; Manai, Hela; Hui, David S; Kanda, Seema; Kawano-Dourado, Leticia; Kim, Yae-Jean; Kissoon, Niranjan; Kwizera, Arthur; Laake, Jon Henrik; Machado, Flavia R; Qadir, Nida; Sarin, Rohit; Shen, Yinzhong; Zeng, Linan; Brignardello-Petersen, Romina; Lytvyn, Lyubov; Siemieniuk, Reed; Zeraatkar, Dena; Bartoszko, Jessica; Ge, Long; Maguire, Brittany; Rochwerg, Bram; Guyatt, Gordon; Vandvik, Per Olav
Published inBMJ (Clinical Research Edition), vol. 370, m3379
Publication date2020
Abstract
Keywords
- Adrenal Cortex Hormones/therapeutic use
- Betacoronavirus
- Coronavirus Infections/drug therapy
- Humans
- Pandemics
- Pneumonia
- Viral/drug therapy
- World Health Organization
Affiliation
Citation (ISO format)
LAMONTAGNE, François et al. A living WHO guideline on drugs for covid-19. In: BMJ (Clinical Research Edition), 2020, vol. 370, p. m3379. doi: 10.1136/bmj.m3379
Main files (1)
Article (Published version)
Identifiers
- PID : unige:142282
- DOI : 10.1136/bmj.m3379
- PMID : 32887691
Commercial URLhttps://www.bmj.com/content/370/bmj.m3379
ISSN of the journal0959-8138
